Briefcases -- Drugs -- ULORIC (febuxostat) by Takeda Pharmaceuticals U.S.A., Inc.

ULORIC (febuxostat) by Takeda Pharmaceuticals U.S.A., Inc.

Case Files
News
Committees
Request a Document
Request
Search Within Briefcase

Folders

  1. Single Event Case Filings
  2. Media References
  3. FDA Regulatory Materials

Quick Access

  1. Uloric (febuxostat) FDA Boxed Warning for Increased Death Risk (February 21, 2019)
  2. Uloric (febuxostat) MTN News Alert re Emerging Uloric Litigation (February 28, 2019)
  3. Uloric (febuxostat) FDA Safety Announcement re Evaluation of Increased Death Risks from All Causes (November 15, 2017)